Zolmitriptan Structure (Structure)
Zolmitriptan Od Tablet, Orally Disintegrating
Product Images NDC 59746-461
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan Od (NDC 59746-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Jubilant Cadista Pharmacuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
2.5 mg Carton (Carton 2.5 mg)
This is a description of a medication, Zolmitriptan Orally Disintegrating Tablets, with a strength of 2.5mg and NDC code 59746-461-16. The text includes information about the manufacturer, dosing and usage instructions, storage requirements, and a caution to keep all medications out of reach of children. However, the text is poorly scanned and contains errors and typos, making it difficult to read and understand.*
5 mg Blister Carton (Carton 5 mg)
This is a description of a medication called "CADISTAY" which contains orally disintegrating tablets of Zolmitriptan. Each tablet contains 5mg of Zolmitriptan. The recommended use and dosage information is provided in the accompanying prescribing information. It is important to keep this medication and all medications out of reach of children. The storage temperature for the medication is between 20°C-25°C, with excursions permitted between 15°C-30°C. The medication should be protected from light and moisture. The text also includes a National Drug Code (NDC) number for the medication.*
Fig 1 (Figure 1)
This appears to be a graph or chart displaying the estimated probability of response for different dosages of Zolmitriptan over a period of 4 hours. The dosages include 1mg, 25mg, and 5mg, and a placebo is also included for comparison. The X-axis represents time from the initial dose, while the Y-axis represents the probability of response.*
Fig 2 (Figure 2)
Fig 3 (Figure 3)
This appears to be a chart or graph displaying the effectiveness of Zolmitriptan Orally Disintegrating Tablets (at a 2.5 mg dosage) compared to a placebo. The percentages listed suggest the degree of effectiveness of each treatment option. The chart also appears to show the time elapsed after the initial dose in increments of 0.5 hours, up to 2 hours.*
Fig 4 (Figure 4)
The text describes the medication "Zolmitriptan Orally Disintegrating Tablets" with a concentration of 2.5 mg. It also includes a graph showing the estimated probability of remedication or rescue over time (in hours) from the initial dose.*
2.5 mg Foil (Foil 2.5 mg)
This is a description of a medication called Zolmitriptan, which comes in an orally disintegrating tablet form with a strength of 2.5mg or 4.25mg. It should be protected from light and moisture. The medication is produced by a company called Dubilant Cadista Pharmamu(\ca\s Inc, and the text includes a lot number and a neutral code.*
5 mg Blister Foil (Foil 5 mg)
Zolmitriptan Orally Disintegrating Tablet is a medication produced by Jubian Cadista Pharmaseuficas Inc. It is protect from light and moisture. The product has a Neutral Code No. UKIDrugs/S8iUAI2007 and should be kept in a dry place.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
